Speaking at a media roundtable on “Bridging Innovation and Affordability in Cancer Care”, organised by the Indian Cancer Society (ICS), the experts said that although cancer treatment has advanced significantly, access remains limited due to high costs, inadequate insurance coverage, limited diagnostic facilities and unequal healthcare infrastructure.
India needs national strategy to improve access to new cancer therapies: Experts

